Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
ColorNephroNet: Kidney tumor malignancy prediction using medical image colorization
0
Zitationen
7
Autoren
2022
Jahr
Abstract
Renal tumor malignancy classification is one of the crucial tasks in urology, being a primary factor included in the decision of whether to perform kidney removal surgery (nephrectomy) or not. Currently, tumor malignancy prediction is determined by the radiological diagnosis based on computed tomography (CT) images. However, it is estimated that up to 16% of nephrectomies could have been avoided because the tumor that had been diagnosed as malignant, was found to be benign in the postoperative histopathological examination. The excess of false-positive diagnoses results in unnecessarily performed nephrectomies that carry the risk of periprocedural complications. In this paper, we present a machine-aided diagnosis system that predicts the tumor malignancy based on a CT image. The prediction is performed after radiological diagnosis and is used to capture false-positive diagnoses. Our solution is able to achieve a 0.84 F1-score in this task. We also propose a novel approach to knowledge transfer in the medical domain in terms of colorization based pre-processing that is able to increase the F1-score by up to 1.8pp.
Ähnliche Arbeiten
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 · 15.272 Zit.
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
2013 · 6.533 Zit.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
2015 · 5.834 Zit.
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 · 5.725 Zit.
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 · 4.767 Zit.